Spotlight Poster Discussion 7 – Thursday, December 9, 2021: 7:00 am – 8:30 am CT
   
  Locoregional Treatment: De-Escalation in Breast Cancer
PD7-01 Withdrawn
PD7-02 Intelligent vacuum-assisted breast biopsy to identify breast cancer patients with pathologic complete response after neoadjuvant systemic treatment for omission of breast and axillary surgery
Pfob A, Sidey-Gibbons C, Rauch G, Thomas B, Schaefgen B, Kuemme S, Reimer T, Hahn M, Thill M, Blohmer J-U, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Degenhardt T, Rom J, Rody A, Große R, van Mackelenbergh1 M, Reinisch M, Karsten M, Golatta M, Heil J. Heidelberg University Hospital, Heidelberg, Germany; The University of Texas MD Anderson Cancer Center, Houston, TX; Institute of Biometry and Clinical Epidemiology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Kliniken Essen-Mitte, Essen, Germany; University Hospital Rostock, Rostock, Germany; University Hospital Tuebingen, Tuebingen, Germany; Agaplesion Markus Hospital Frankfurt, Frankfurt, Germany; University Hospital Berlin, Berlin, Germany; Marienhospital, Witten, Witten, Germany; University of Cologne, Cologne, Germany; University Hospital Ulm, Ulm, Germany; Jerusalem Hospital Hamburg, Hamburg, Germany; Klinikum Bielefeld Mitte GmbH, Bielefeld, Germany; Visiorad, Pinneberg, Germany; Hospital rechts der Isar, Munich, Germany; University Hospital Munich, Munich, Germany; Klinikum Frankfurt-Höchst, Frankfurt, Germany; University Hospital Schleswig-Holstein, Luebeck, Germany; University Hospital Halle, Halle, Germany.
PD7-03 Withdrawn
PD7-04 Avoidance of radiotherapy for low risk early breast cancer using LUMINA Trial criteria and accounting for endocrine therapy adherence
Seol SW, Weller L, Pflederer T, Goodman C, Donnelly ED, Hayes JP, Strauss JB. Northwestern University Feinberg School of Medicine, Chicago, IL; Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; University of Illinois at Chicago College of Medicine, Chicago, IL; The University of Texas MD Anderson Cancer Center, Houston, TX.
PD7-05 A multicenter prospective study to predict pathologic complete response by vacuum-assisted breast biopsy based on MRI and US findings after neoadjuvant chemotherapy
Hayashi N, Teruya N, Kuwayama T, Kojima Y, Ohde S, Nakayama S, Tazo M, Takei H, Ueno T, Iwase T, Ohno S, Yamauchi H, Akiyama F, Tsunoda H, Tsugawa K, Nakamura S. St. Luke's International Hospital, Tokyo, Japan; The Cancer Institute Hospital of JFCR, Tokyo, Japan; Showa University School of Medicine, Tokyo, Japan; St Marianna University School of Medicine Hospital, Tokyo, Japan; St. Luke's International University, Tokyo, Japan; Nippon Medical School Hospital, Tokyo, Japan.
PD7-06 Trends in surgical resection for stage IV breast cancer: Less surgery more systemic treatment
Douglas SR, Lizarraga I, Boughey JC, Weiss A, Hunt K, Dickson-Witmer D, Subhedar PD, Park KU, Zhao B, Blair S. UC San Diego, La Jolla, CA; University of Iowa Hospitals and Clinics, Iowa City, IA; Mayo Clinic, Rochester, MN; Dana-Farber Cancer Institute, Boston, MA; MD Anderson Cancer Center, Houston, TX; Beebe Healthcare, Lewes, DE; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA; The Ohio State University James Comprehensive Cancer Center, Columbus, OH.
PD7-07 Surgical management and contralateral breast cancer risk in women with a history of radiation therapy for Hodgkin lymphoma: Results from a population-based cohort
Eisenberg ER, Weiss A, Prakash I, Skamene S, Basik M, Boileau JF, Ajjamada L, Pollak M, Wong SM. JGH Segal Cancer Centre, McGill University, Montreal, QC, Canada; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA; McGill University Health Centre, Montreal, QC, Canada.
PD7-08 Less is not necessarily more: A propensity matched national analysis on effect and outcome of sentinel lymph node biopsy omission
Cao L, Miller ME, Rothermel LD, Montero AJ, Towe CW, Shenk R. University Hospitals Cleveland Medical Center, Cleveland, OH.
PD7-09 Safety of conservative surgery with accelerated partial breast re-irradiation for isolated ipsilateral breast cancer recurrence regardless of immunohistochemical subtype. A multicentric prospective study
Espinosa-Bravo M, Reyes Lopez V, Morales Comas C, Rivero Déniz J, de La Torre Fernández de Vega J, Vives Roselló I, Sisó Raber C, Altabas Gonzalez M, Giraldo Marin A, Alonso I, Argudo N, Nicolau P, Algara M, Sanz X, Caparrós X, Oses G, Saez J, Vernet-Tomas M, Mollà M. Breast Surgical Unit. Breast Cancer Center. Gynecology Department. Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus. Universitat Autònoma de Barcelona., Barcelona, Spain; Breast Radiotherapy. Radiotherapy Department. Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus. Universitat Autònoma de Barcelona., Barcelona, Spain; Department of Gynecology Oncology. Hospital Clínic Barcelona, Barcelona, Spain; Breast Unit and General Surgery Department, Hospital del Mar, Barcelona, Spain; Radiation Oncology Department. Hospital del Mar, Barcelona, Spain; Department of Radiation Oncology. Hospital Clínic Barcelona, Barcelona, Spain; Breast Surgery, Gynaecology Department. Hospital del Mar, Barcelona, Spain.